From the Journals

Girls with congenital diaphragmatic hernia have lower survival rates


 

TOPLINE:

Girls born with congenital diaphragmatic hernia (CDH), a rare birth defect that affects approximately one in 3,600 babies in the United States, are slightly less likely to survive than their male counterparts with the condition, a study published in the Journal of Pediatrics has found.

METHODOLOGY:

  • The retrospective cohort study used demographic, clinical, and outcomes data from the registry to investigate the role of biological sex for babies with CDH.
  • The study included more than 7,200 newborns at 105 hospitals across 17 countries from January 2007 to December 2018.
  • The primary outcomes were 30-day, 60-day, and in-hospital mortality.
  • The secondary outcomes included weight gain during admission, feeding, and oxygen status at 30 days and at discharge.

TAKEAWAY:

  • After controlling for markers of disease severity, girls with CDH had a 32% increased risk for death at 30-days (adjusted hazard ratio, 1.32; P = .02).
  • Girls had lower survival rates at 30 days (77.3%), compared with boys (80.1%).
  • The disparity remained at 60 days, with the survival rate for girls with CDH (73.5%) modestly lower than that for boys (77.2%), and also at discharge – 70.2%, compared with 74.2%, respectively.
  • The survival differences between boys and girls primarily affected babies who did not undergo cannulation; in this group, the survival rate for girls was 77.5%, compared with 82.1% for boys.
  • Girls with CDH weighed less at birth (2.8 kg) than boys with the condition (3 kg); birth weight is a for babies with CDH, .

IN PRACTICE:

“Although racial and ethnic outcome disparities have been documented in CDH, disparities between males and females are not well known,” Shaun Kunisaki, MD, MSc, a senior author of the study and professor of surgery at Johns Hopkins University in Baltimore, said in a press release about the findings. “It is really important to understand if those disparities exist, because it may change how we can better manage these patients.”

STUDY DETAILS:

The authors include seven from the division of general pediatric surgery and the division of pediatric respiratory sciences at Johns Hopkins University. Two authors are from the department of pediatric surgery at the University of Texas and Children’s Memorial Hermann Hospital, both in Houston.

LIMITATIONS:

The authors point to potential challenges with data collection, including diagnosis miscoding and missing data. They acknowledge that MRI fetal lung volumes, degree of liver herniation, and emerging markers of socioeconomic status were not available in the database. The study also could not examine long-term outcomes because data were limited to in-hospital variables.

DISCLOSURES:

The authors report no financial conflicts of interest.

A version of this article first appeared on Medscape.com.

Recommended Reading

Cancer, heart disease vaccines may be ready by 2030, Moderna says
MDedge Family Medicine
Answers sought for mental health challenges in pediatric rheumatology patients
MDedge Family Medicine
Study compares noninvasive treatments of cutaneous neurofibromas
MDedge Family Medicine
FDA gives fast-track approval to new ALS drug
MDedge Family Medicine
Study shifts burden of IgG4-related disease to women
MDedge Family Medicine
Cutaneous vasculitis curtails quality of life
MDedge Family Medicine
FDA OKs new drug for Fabry disease
MDedge Family Medicine
FDA approves autoinjector pen for Humira biosimilar, Cyltezo
MDedge Family Medicine
FDA approves Yuflyma as ninth adalimumab biosimilar
MDedge Family Medicine
Scientists discover variants, therapy for disabling pansclerotic morphea
MDedge Family Medicine